Apsis Pharmaceuticals Private Limited
About Apsis Pharmaceuticals Private Limited
Data last updated:
Apsis Pharmaceuticals Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 31 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24100UP2016PTC083693. Its GSTIN is 09AAPCA4871K1Z1 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Praveen Kumar Singh and Kamalawati Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vidyarathi Book Depot Sahjanwa, Gorakhpur, Uttar Pradesh, India – 273209.
As per the financials filed for FY 2025, the company reported a revenue of ₹42.81 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹6,860 (net margin 0.2%) and EBITDA of ₹6,860 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Apsis Pharmaceuticals Private Limited's registered office is in Gorakhpur, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressVidyarathi Book Depot Sahjanwa, Gorakhpur, Uttar Pradesh, India – 273209
- IndustryChemicals, Manufacturing, Basic Chemical
To see the full contact details of Apsis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Apsis Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Apsis Pharmaceuticals Private Limited, buy the company report.
Financials of Apsis Pharmaceuticals Private Limited
FY 2025 filings availableApsis Pharmaceuticals Private Limited reported revenue of ₹42.81 Lakh (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 1% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6,860 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6,860 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apsis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Apsis Pharmaceuticals Private Limited
Apsis Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen Kumar Singh | Director | 11 Jun 2017 | 9 Years 4 Months | Current |
| Kamalawati Singh | Director | 01 Apr 2017 | 9 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Apsis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apsis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Apsis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAPCA4871K1Z1 | Uttar Pradesh | Active | 19 Oct 2017 |
To see the full GST registrations and return filing status of Apsis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Apsis Pharmaceuticals Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Atul Kumar Singh ceased to be Director on 11 Jun 2017.
Frequently asked questions
Apsis Pharmaceuticals is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 31 May 2016 (10+ years old) and is registered under CIN U24100UP2016PTC083693.
Apsis Pharmaceuticals has 2 current directors:
- Praveen Kumar Singh - Director
- Kamalawati Singh - Director
The latest financial statements of Apsis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Apsis Pharmaceuticals is 09AAPCA4871K1Z1, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Apsis Pharmaceuticals is U24100UP2016PTC083693. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apsis Pharmaceuticals was incorporated on 31 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Atul Kumar Singh ceased to be Director on 11 Jun 2017. Praveen Kumar Singh was appointed as Director on 11 Jun 2017. Kamalawati Singh was appointed as Director on 01 Apr 2017. Apsis Pharmaceuticals has 4 board changes on record in total.
The registered office of Apsis Pharmaceuticals is at Vidyarathi Book Depot Sahjanwa, Gorakhpur, Uttar Pradesh, India – 273209.
Apsis Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Apsis Pharmaceuticals is compliant as of 24 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
